← Back to Patent Explorer
US4262009A Expired / Lapsed US ⏱️ 0.0 years remaining

6- And 1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acid

Assignee: Merck and Co Inc
•
Filing: 1979-12-03
•
Granted: 1981-04-14
•
Expires: 1999-12-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 6- and 1-substituted-1-carbadethiapen-2-em-3-carboxylic acids I of the following structure: <IMAGE> I wherein R1, R2, R3 and R4 are, inter alia, independently selected from the group consisting of alkyl, aryl, and aralkyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David H. Shih

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 03:58
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/14; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/10; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/568

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 144 words
A compound having the structure: ##STR69## and the pharmaceutically acceptable salts thereof; wherein R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of hydrogen, and substituted and unsubstituted: alkyl having 1-6 carbon atoms; phenyl; phenylalkyl wherein the alkyl moiety has 1-6 carbon atoms; cycloalkyl and cycloalkylalkyl having 3 to 6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; and spirocycloalkyl having 3 to 6 carbon atoms; wherein the substituent or substituents on R 1 , R 2 , R 3 and R 4 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di-, and trialkylamino (each alkyl having 1-6 carbon atoms), alkoxyl having 1-6 carbon atoms, cyano and carboxyl; wherein R 1 and R 2 are not hydrogen and R 3 and R 4 are not both hydrogen at the same time.
Claim 2
Dependent Claim 144 words
A compound having the structure: ##STR69## and the pharmaceutically acceptable salts thereof; wherein R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of hydrogen, and substituted and unsubstituted: alkyl having 1-6 carbon atoms; phenyl; phenylalkyl wherein the alkyl moiety has 1-6 carbon atoms; cycloalkyl and cycloalkylalkyl having 3 to 6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; and spirocycloalkyl having 3 to 6 carbon atoms; wherein the substituent or substituents on R 1 , R 2 , R 3 and R 4 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di-, and trialkylamino (each alkyl having 1-6 carbon atoms), alkoxyl having 1-6 carbon atoms, cyano and carboxyl; wherein R 1 and R 2 are not hydrogen and R 3 and R 4 are not both hydrogen at the same time.
Claim 3
Dependent Claim 47 words
A compound according to claim 1 wherein R 1 and R 2 are selected from: alkyl, cyclopropyl, spirocyclopropyl, and benzyl and phenyl; R 4 is alkyl and phenylalkyl substituted by hydroxyl or amino; and R 3 is hydrogen or alkyl or phenylalkyl substituted by hydroxyl or amino.
Claim 4
Dependent Claim 34 words
A compound according to claim 2 wherein R 1 and R 2 are selected from: methyl, ethyl, isopropyl, t-butyl, spirocyclopropyl, or phenyl; R 4 is 1-hydroxyethyl, methyl, or hydroxymethyl; and R 3 is hydrogen.
Claim 5
Dependent Claim 10 words
A compound according to claim 1 having the structure: ##STR70##
Claim 6
Dependent Claim 10 words
A compound according to claim 1 having the structure: ##STR71##
Claim 7
Dependent Claim 26 words
An antibiotic pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1, 2, 3, 4 or 5 and a pharmaceutical carrier therefor.
Claim 8
Independent Claim 22 words
A method of treatment comprising administering an antibiotically effective amount of a compound according to claims 1, 2, 3, 4 or 5.

References Cited (Backward Citations)

US4181733A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-04-13 1984-10-13 1985-04-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-04-13 1988-10-13 1989-04-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-04-13 1992-10-13 1993-04-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag